![M. Wilsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Wilsey
Vorsitzender bei
SAREPTA THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 31.05.2026
Profil
Dr. M. K. Wilsey ist Chairman bei MiMedx Group, Inc. und unabhängiges Mitglied des Verwaltungsrats bei IGM Biosciences, Inc. und Chairman bei Sarepta Therapeutics, Inc. Sie ist Mitglied des Board of Directors von IGM Biosciences, Inc. Dr. Wilsey war zuvor als unabhängiger Director bei Amylin Pharmaceuticals, Inc. beschäftigt, als President & Chief Executive Officer bei KEW Group, Inc. ein Mitglied des President's Council of Advisors on Science & Technology, ein Director-Science, Technology & Economic Policy bei The National Research Council, ein Managing Director bei RS Investment Management Co. LLC, Vorsitzende & Präsidentin der National Venture Capital Association, Geschäftsführerin & General Partner von Robertson Stephens & Co. und Mitbegründerin der Coalition for 21st Century Medicine. Sie war auch im Vorstand von Abgenix, Inc. Sie erhielt ihren Bachelor-Abschluss von der University of California, Davis und einen Doktortitel von der University of California, Davis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 224’357 ( 0.21% ) | 4 Mio $ | 31.05.2026 | |
MIMEDX GROUP, INC. 0.14% | 18.06.2025 | 212’771 ( 0.14% ) | 782 997 $ | 31.05.2026 |
Aktive Positionen von M. Wilsey
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Vorsitzender | 16.04.2015 |
| MIMEDX GROUP, INC. | Vorsitzender | 19.06.2019 |
Ehemalige bekannte Positionen von M. Wilsey
| Unternehmen | Position | Ende |
|---|---|---|
| IGM BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 14.08.2025 |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Vorstandsvorsitzender | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Direktor/Vorstandsmitglied | 08.08.2012 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Corporate Officer/Principal | 01.12.2009 |
President's Council of Advisors on Science & Technology
 President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Corporate Officer/Principal | 01.01.2009 |
Ausbildung von M. Wilsey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Finance |
Robertson Stephens & Co.
 Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
President's Council of Advisors on Science & Technology
President's Council of Advisors on Science & Technology General GovernmentGovernment Provides the Administration services to science and technology | Government |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
The Coalition for 21st Century Medicine
 The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine's mission is to improve the quality of healthcare by encouraging research, development, and commercialization of innovative diagnostic technologies that will personalize patient care, improve patient outcomes, and substantially reduce healthcare costs. The company is based in Arlington, VA. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, and Patrick F. Terry. | Commercial Services |
Board On Science Technology & Economic Policy | |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
